Hotline:86-10-67887855 
简体中文Olopatadine hydrochloride tablets has been approved by China SF
Release time：2022-11-17 15:38:44
Our new formulation Olopatadine hydrochloride tablets (5mg ) has been approved by China SFDA on 31st May 2022. The tablets registration certificate No. is H20213892 and H20223350.
Reprint statement: reprint please indicate "source: Wista pharma".
Recommend
-
2022-11-17Nafcillin Sodium for injection has been approved by China SF
-
2022-11-17Our new formulation L-Ornithine-L-Aspartate Infusion for injection has been approved
-
2022-11-17Voriconazole tablets has been approved by China SF
-
2022-11-17Olopatadine hydrochloride tablets has been approved by China SF
-
2022-11-17Luliconazole and posaconazole are launched into market
86-10-67887855
Head Office：
Marketing：
Wista Pharmam
86-10-67887855